Wed, May 14, 8:07 PM (9 days ago)
**DBV Technologies S.A. (DBVT) 10-K/A Summary** **Company Overview:** DBV Technologies S.A. (DBVT) is a French biotechnology company listed on the Nasdaq Stock Market. The 10-K/A amendment focuses on correcting beneficial ownership information and updating the description of registered securities. **Financial Performance:** The amendment does not include financial statements or update financial performance metrics such as revenue, net income, or earnings per share. The original 10-K filing should be referenced for detailed financial information. **Strategic Overview and Future Outlook:** The amendment does not provide new strategic insights or future outlook. The company's strategic direction and future plans can be found in the original 10-K filing. **Risk Factors:** The amendment does not introduce new risk factors. Existing risk factors are outlined in the original 10-K filing. **Financial Condition:** The financial condition remains unchanged as the amendment does not include financial statements or updates to the financial condition. **Market Position Changes:** The amendment does not report any changes in market position. The company's market position can be inferred from the original 10-K filing and subsequent filings. **Changes Made in the Amendment:** 1. **Beneficial Ownership Table:** Corrected and updated beneficial ownership information for 5% shareholders, including entities affiliated with Baker Bros. Advisors LP, Bpifrance Participations S.A., Suvretta, Vivo Opportunity Fund, MPM BioImpact LLC, Adage Capital Partners, Janus, Octagon Opportunities Fund II LP, VR Advisor, LLC, and Citadel CEMF Investments Ltd. 2. **Description of Registered Securities:** Updated the description of American Depositary Shares to reflect immaterial changes. **Impact of Changes:** The changes are immaterial and do not affect the company's financial condition or operations. The updates ensure accuracy in shareholder information and regulatory compliance. **Auditor Information:** The company's auditors are Deloitte & Associés and KPMG S.A., both based in Paris, France. **Conclusion:** The 10-K/A amendment by DBV Technologies S.A. primarily corrects beneficial ownership information and updates the description of registered securities. For comprehensive financial and strategic information, refer to the original 10-K filing and subsequent reports.